12.07.2015 Views

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

A <strong>Clinical</strong> <strong>Guide</strong> <strong>to</strong> <strong>Supportive</strong> <strong>and</strong> <strong>Palliative</strong> <strong>Care</strong> <strong>for</strong> <strong>HIV</strong>/<strong>AIDS</strong> • Chapter 4: PainTable 4-12: <strong>AIDS</strong> Clinicians’ Ratings of Barriers <strong>to</strong> Pain Management# Barrier Percent26 picas1. Lack of knowledge regarding pain management 51.82. Reluctance <strong>to</strong> prescribe opioids 51.53. Lack of access <strong>to</strong> pain specialists 50.94. Concern regarding drug addiction <strong>and</strong>/or abuse 50.55. Lack of psychological support/drug treatment services 43.06. Patient reluctance <strong>to</strong> report pain 24.07. Patient reluctance <strong>to</strong> take opioids 24.0IVSource: Breitbart W, Kaim M, Rosenfeld B. Clinicians’ perceptions of barriers <strong>to</strong> pain management in <strong>AIDS</strong>. J Pain Symp<strong>to</strong>mManage 18:203-12, 1999.Managing pain in <strong>AIDS</strong> patients with a his<strong>to</strong>ry of substance use is a particularly challengingproblem that <strong>HIV</strong> providers will face with increasing frequency. Table 4-13 identifies basic interventions<strong>for</strong> pain management in substance users. For more in<strong>for</strong>mation, see Chapter 11: Substance UseProblemsTable 4-13: An Approach <strong>to</strong> Pain Management in Substance Users with <strong>HIV</strong> Disease1. Substance users with <strong>HIV</strong> disease deserve pain control; we have an obligation <strong>to</strong> treatpain <strong>and</strong> suffering in all of our patients.2. Accept <strong>and</strong> respect the report of pain.3. Be careful about the label substance abuse; distinguish between <strong>to</strong>lerance, physicaldependence <strong>and</strong> addiction (psychological dependence or drug abuse).4. Not all substance users are the same; distinguish between active users, individuals inmethadone maintenance, <strong>and</strong> those in recovery.5. Individualize pain treatment.6. Utilize the principles of pain management outlined <strong>for</strong> all patients with <strong>HIV</strong> disease <strong>and</strong>pain (WHO Ladder).7. Set clear goals <strong>and</strong> conditions <strong>for</strong> opioid therapy: set limits, recognize drug abuse behaviors,make consequences clear, use written contracts <strong>and</strong> establish a single prescriber.8. Use a multidimensional approach: pharmacologic <strong>and</strong> nonpharmacologic interventions,attention <strong>to</strong> psychosocial issues, team approach.CONCLUSION■ Pain in <strong>AIDS</strong>, even in this era of protease inhibi<strong>to</strong>rs <strong>and</strong> decreased <strong>AIDS</strong> death rates, is a clinicallysignificant problem contributing greatly <strong>to</strong> psychological <strong>and</strong> functional morbidity. Pain can beadequately treated <strong>and</strong> so must be a focus of palliative care of the person living with <strong>HIV</strong>/<strong>AIDS</strong>.U.S. Department of Health <strong>and</strong> Human Services • Health Resources <strong>and</strong> Services Administration • <strong>HIV</strong>/<strong>AIDS</strong> Bureau 117

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!